ROOBY Trial Follow-up Extension
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01924442 |
Recruitment Status :
Completed
First Posted : August 16, 2013
Results First Posted : June 7, 2019
Last Update Posted : June 7, 2019
|
Sponsor:
VA Office of Research and Development
Information provided by (Responsible Party):
VA Office of Research and Development
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Observational |
---|---|
Study Design | Observational Model: Cohort; Time Perspective: Prospective |
Conditions |
All Cause Mortality MACE |
Enrollment | 2203 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | On-Pump | Off-Pump |
---|---|---|
![]() |
Cardiac bypass using Heart Lung Machine | Cardiac bypass surgery on beating heart |
Period Title: Overall Study | ||
Started | 1099 | 1104 |
Completed | 1059 | 967 |
Not Completed | 40 | 137 |
Baseline Characteristics
Arm/Group Title | On-Pump | Off-Pump | Total | |
---|---|---|---|---|
![]() |
Cardiac bypass using Heart Lung Machine | Cardiac bypass surgery on beating heart | Total of all reporting groups | |
Overall Number of Baseline Participants | 1099 | 1104 | 2203 | |
![]() |
[Not Specified]
|
|||
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
<=18 years |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Between 18 and 65 years |
699 63.6%
|
671 60.8%
|
1370 62.2%
|
|
>=65 years |
400 36.4%
|
433 39.2%
|
833 37.8%
|
|
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
62.5 (8.5) | 63.0 (8.5) | 62.74 (8.49) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
Female |
6 0.5%
|
7 0.6%
|
13 0.6%
|
|
Male |
1093 99.5%
|
1097 99.4%
|
2190 99.4%
|
|
Race/Ethnicity, Customized
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
Black |
93 8.5%
|
77 7.0%
|
170 7.7%
|
|
Hispanic |
52 4.7%
|
71 6.4%
|
123 5.6%
|
|
White |
926 84.3%
|
931 84.3%
|
1857 84.3%
|
|
Other |
27 2.5%
|
25 2.3%
|
52 2.4%
|
|
Unknown |
1 0.1%
|
0 0.0%
|
1 0.0%
|
|
Urgent Status requiring surgery within 12 to 72 hours
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
146 13.3%
|
146 13.2%
|
292 13.3%
|
||
Chronic obstructive pulmonary disease (COPD)
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
238 21.7%
|
220 19.9%
|
458 20.8%
|
||
Peripheral vascular disease
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
163 14.8%
|
179 16.2%
|
342 15.5%
|
||
Diabetes
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
491 44.7%
|
470 42.6%
|
961 43.6%
|
||
Hypertension
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
952 86.6%
|
948 85.9%
|
1900 86.2%
|
||
History of Depression
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 1099 participants | 1104 participants | 2203 participants | |
120 10.9%
|
146 13.2%
|
266 12.1%
|
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Frederick Grover, MD |
Organization: | VA Medical Center, Denver, Colorado |
Phone: | 303-724-2798 |
EMail: | Frederic.Grover@ucdenver.edu |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT01924442 |
Other Study ID Numbers: |
517-FS |
First Submitted: | July 18, 2013 |
First Posted: | August 16, 2013 |
Results First Submitted: | September 1, 2017 |
Results First Posted: | June 7, 2019 |
Last Update Posted: | June 7, 2019 |